SURGW yields 22988.51% · MRK yields 2.76%● Live data
📍 SURGW pulled ahead of the other in Year 1
Combined, SURGW + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SURGW + MRK for your $10,000?
SurgePays, Inc. operates as a technology and telecommunications company. It offers mobile broadband services to consumers. The company's fintech platform utilizes a suite of financial and prepaid products to convert corner stores and bodegas into tech-hubs for underbanked neighborhoods. The company also provides ShockWave, an end-to-end cloud-based Software as a Service offering an Omnichannel customer relationship management, billing system, and carrier integrations to the telecommunication and broadband industry. In addition, the company provides Surge Blockchain software, a back-office marketplace offering wholesale consumable goods direct to convenience stores who are transacting on the SurgePays Fintech platform. Further, it offers lead generation and case management solutions primarily to law firms in the mass tort industry. The company was incorporated in 2006 and is headquartered in Bartlett, Tennessee.
Full SURGW Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.